Loading organizations...
Loading organizations...
Innovative solutions for targeted delivery of therapeutic agents.
RenovoRx has raised $17.3M across 3 funding rounds.
RenovoRx has raised $17.3M in total across 3 funding rounds.
RenovoRx has raised $17.3M in total across 3 funding rounds.
RenovoRx's investors include Boston Scientific, Acorn Campus Taiwan, Astia Angels, btov Partners, Golden Seeds, Halo Fund III, The Angels' Forum, Amidzad Partners, Sand Hill Angels.
RenovoRx has raised $17.3M across 3 funding rounds. Most recently, it raised $6.1M Other Equity in January 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 29, 2024 | $6.1M Other Equity | ||
| May 23, 2018 | $10.0M Other Equity | Boston Scientific | Acorn Campus Taiwan, Astia Angels, btov Partners, Golden Seeds, Halo Fund III, The Angels' Forum |
| Jan 28, 2014 | $1.1M Series B | Golden Seeds | Amidzad Partners, Astia Angels, Halo Fund III, Sand Hill Angels, The Angels' Forum |